🚀 ProPicks AI Hits +34.9% Return!Read Now

Pope to endorse principles on AI ethics with Microsoft, IBM

Published 28/02/2020, 08:22
© Reuters. Pope Francis visits Bari
MSFT
-
IBM
-

By Jeffrey Dastin

(Reuters) - Vatican officials on Friday planned to release principles promoting the ethical use of artificial intelligence (AI), with the backing of Microsoft Corp (O:MSFT) and International Business Machines Corp (N:IBM) as the first two technology industry sponsors.

The "Rome Call for AI Ethics" asserts that the technology should respect privacy, work reliably and without bias, consider "the needs of all human beings" and operate transparently - an area of ongoing research because AI systems' decisions are often inscrutable.

The document reflects growing interest among companies and institutions to set guardrails for the fast-evolving technology. Police have used facial recognition systems to investigate crimes, and Fortune 500 companies have used AI to vet job applicants - both examples of high-stakes tasks where deploying inaccurate or biased software could lead to harm.

The Vatican's initiative grew out of concerns that Pope Francis raised about AI and its effect on society more than a year ago, according to John Kelly III, executive vice president of IBM and one of the signatories.

"His major concerns were, will it be available to everyone, or is it going to further bifurcate the haves and the have-not's?" Kelly told Reuters in an interview. Vatican officials also had concerns about AI displacing jobs and met with IBM in the United States at a research centre in September, he said.

Pope Francis was due to receive the document Friday to conclude a conference that the Vatican's Pontifical Academy for Life hosted this week on AI ethics. Others participating included the European Parliament's President David Sassoli and Microsoft's President Brad Smith.

It was not immediately clear which other technology companies might sign on to the document going forward, or how signatories would implement the principles.

IBM for instance wants a doctor to be in the loop when its AI makes healthcare recommendations - something that may increase over time following a deal it announced this week with the Bambino Gesù Children's Hospital in Rome. That partnership will focus on developing technology to speed up diagnosis and treatment of brain tumour patients.

Both IBM and Microsoft have said they turned down business when they felt uncomfortable with how a customer wanted to use their technology. Still, according to Kelly, about a third of the ethics questions IBM typically faces have no obvious answer.

© Reuters. Pope Francis visits Bari

"Going forward we're going to see more falling in that category, only because the technology is advancing so fast," he said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.